Cargando…

Association between DNA methylation of HSPB1 and death in low Gleason score prostate cancer

BACKGROUND: Heat shock protein 27 (Hsp-27) encoded by gene HSPB1 is a critical regulator of the behavioral phenotype of human prostate cancer (PCa) cells, enhanced expression being associated with highly aggressive disease and poor clinical outcome. In contrast, the protein is not expressed in PCas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vasiljević, N, Ahmad, A S, Beesley, C, Thorat, M A, Fisher, G, Berney, D M, Møller, H, Yu, Y, Lu, Y-J, Cuzick, J, Foster, C S, Lorincz, A T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572391/ https://www.ncbi.nlm.nih.gov/pubmed/23165430 http://dx.doi.org/10.1038/pcan.2012.47

Ejemplares similares

DNA methylation gene-based models indicating independent poor outcome in prostate cancer
por: Vasiljević, Nataša, et al.
Publicado: (2014)

A novel DNA methylation score accurately predicts death from prostate cancer in men with low to intermediate clinical risk factors
por: Ahmad, Amar S., et al.
Publicado: (2016)

Phospholipase D2 in prostate cancer: protein expression changes with Gleason score
por: Noble, Amanda R., et al.
Publicado: (2019)

MYC DNA Methylation in Prostate Tumor Tissue is Associated with Gleason Score
por: Barry, Kathryn Hughes, et al.
Publicado: (2020)

Prognostic value of Ki-67 for prostate cancer death in a conservatively managed cohort
por: Fisher, G, et al.
Publicado: (2013)

Beyond the Gleason score: the prognostic significance of prostate cancer subtypes
por: Flood, Trevor A., et al.
Publicado: (2018)

Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome
por: Berney, Daniel M, et al.
Publicado: (2016)

Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort
por: Cuzick, J, et al.
Publicado: (2012)

Absolute Quantitation of DNA Methylation of 28 Candidate Genes in Prostate Cancer Using Pyrosequencing
por: Vasiljeviš, Nataڑa, et al.
Publicado: (2011)

Multimodal Radiomic Features for the Predicting Gleason Score of Prostate Cancer
por: Chaddad, Ahmad, et al.
Publicado: (2018)

Validation of an RNA cell cycle progression score for predicting death from prostate cancer in a conservatively managed needle biopsy cohort
por: Cuzick, J, et al.
Publicado: (2015)

Biochemical Recurrence in Gleason Score 7 Prostate Cancer in Korean Men: Significance of the Primary Gleason Grade
por: Ro, Yun Kwan, et al.
Publicado: (2012)

HSPB1, HSPB6, HSPB7 and HSPB8 Protect against RhoA GTPase-Induced Remodeling in Tachypaced Atrial Myocytes
por: Ke, Lei, et al.
Publicado: (2011)

Validation of the WHO 2016 new Gleason score of prostatic carcinoma
por: Rao, Vishal, et al.
Publicado: (2018)

Expression of stromal elements of prostatic adenocarcinoma in different gleason scores
por: Osorio, Clarice Fraga Esteves Maciel, et al.
Publicado: (2019)

The Ability of Prostate Health Index (PHI) to Predict Gleason Score in Patients With Prostate Cancer and Discriminate Patients Between Gleason Score 6 and Gleason Score Higher Than 6—A Study on 320 Patients After Radical Prostatectomy
por: Dolejsova, Olga, et al.
Publicado: (2018)

The correlation between the gleason score of the biopsy and that of the prostatectomy patch
por: Bai, W., et al.
Publicado: (2021)

Validation of an MRI-based prostate cancer prebiopsy Gleason score predictive nomogram
por: Lee, Adrianna Jiaying, et al.
Publicado: (2022)

A comparison of methylation levels in HPV18, HPV31 and HPV33 genomes reveals similar associations with cervical precancers()
por: Vasiljević, Nataša, et al.
Publicado: (2014)

Long-term outcome among men with conservatively treated localised prostate cancer
por: Cuzick, J, et al.
Publicado: (2006)

Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study
por: Berney, D M, et al.
Publicado: (2009)

The percentage of high‐grade prostatic adenocarcinoma in prostate biopsies significantly improves on Grade Groups in the prediction of prostate cancer death
por: Berney, Daniel M, et al.
Publicado: (2019)

The values of neutrophil-lymphocyte ratio and/or prostate-specific antigen in discriminating real Gleason score ≥ 7 prostate cancer from group of biopsy-based Gleason score ≤ 6
por: Wang, Hanfeng, et al.
Publicado: (2017)

Overall and worst gleason scores are equally good predictors of prostate cancer progression
por: Tolonen, Teemu T, et al.
Publicado: (2011)

Credentialing of DNA methylation assays for human genes as diagnostic biomarkers of cervical intraepithelial neoplasia in high-risk HPV positive women
por: Vasiljević, Nataša, et al.
Publicado: (2014)

Correlation of Gleason Scores with Diffusion-Weighted Imaging Findings of Prostate Cancer
por: Nagarajan, Rajakumar, et al.
Publicado: (2012)

Predicting Gleason Score of Prostate Cancer Patients Using Radiomic Analysis
por: Chaddad, Ahmad, et al.
Publicado: (2018)

Favorable intermediate risk prostate cancer with biopsy Gleason score of 6
por: Oh, Jong Jin, et al.
Publicado: (2021)

Epigenetic signature of Gleason score and prostate cancer recurrence after radical prostatectomy
por: Geybels, Milan S., et al.
Publicado: (2016)

Recent decline in prostate cancer incidence in the United States, by age, stage, and Gleason score
por: Herget, Kimberly A., et al.
Publicado: (2015)

Development and validation of a deep learning algorithm for improving Gleason scoring of prostate cancer
por: Nagpal, Kunal, et al.
Publicado: (2019)

Serum insulin level, disease stage, prostate specific antigen (PSA) and Gleason score in prostate cancer
por: Lehrer, S, et al.
Publicado: (2002)

AB177. Clinical and pathological research of prostate cancer with Gleason score 10
por: Yan, Bin, et al.
Publicado: (2016)

Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer
por: Reid, A H M, et al.
Publicado: (2010)

Correlation of MRI-Lesion Targeted Biopsy vs. Systematic Biopsy Gleason Score with Final Pathological Gleason Score after Radical Prostatectomy
por: Wenzel, Mike, et al.
Publicado: (2021)

Hsp-27 expression at diagnosis predicts poor clinical outcome in prostate cancer independent of ETS-gene rearrangement
por: Foster, C S, et al.
Publicado: (2009)

Predictive Factors of Gleason Score Upgrading in Localized and Locally Advanced Prostate Cancer Diagnosed by Prostate Biopsy
por: Moon, Seung Jin, et al.
Publicado: (2010)

Molecular risk classifier score and biochemical recurrence risk are associated with cribriform pattern type in Gleason 3+4=7 prostate cancer
por: Greenland, Nancy Y., et al.
Publicado: (2022)

Human HspB1, HspB3, HspB5 and HspB8: Shaping these disease factors during vertebrate evolution
por: Benndorf, Rainer, et al.
Publicado: (2022)

Validation of the cell cycle progression score to differentiate indolent from aggressive prostate cancer in men diagnosed through transurethral resection of the prostate biopsy
por: Cuzick, Jack M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_iaf4kfmn2a5b0tqcfgg4eine58